The Cancer Letter, an independent weekly news publication, has been the leading source for information on the issues that shape oncology since 1973, two years after Congress passed the National Cancer Act of 1971.
The Cancer Letter provides authoritative, award-winning coverage of the development of cancer therapies, drug regulation, legislation, cancer research funding, health care finance, and public health. Our coverage focuses on the National Cancer Institute, National Institutes of Health, Food & Drug Administration, U.S. Congress, cancer centers, and the pharmaceutical industry
Articles of a historical nature published by The Cancer Letter are outside the paywall and provided as excerpts on the Cancer History Project.